NIH Grants $2.25M to Tempo Therapeutics for Innovative Wound Healing Study
The NIH has awarded a **$2.25 million** SBIR grant to **Tempo Therapeutics** for a clinical trial on their MAP™ Wound Matrix technology. This funding underscores the federal commitment to support innovative biomedical solutions aimed at improving patient outcomes in wound care, creating potential avenues for contractors specializing in advanced medical device technology.